European Archives - Page 121 of 1264 - European Medical Journal

Intravascular Imaging Improves PCI Outcomes in Complex Coronary Lesions

Understand how IVI guidance reduces PCI complications in complex coronary lesions, outperforming angiography alone.

EULAR 2025: Five Distinct Phenotypes Identified in Behçet’s Syndrome Using AI-Powered Clustering

A new EULAR 2025 study has redefined Behçet’s syndrome subtypes using latent class analysis, revealing five unique phenotypes that may inform personalized treatment strategies.

New AI System Improves Survival Predictions for Patients with Liver Cancer

Researchers have developed an AI-based multimodal fusion system that combines CT imaging and clinical data to predict survival in patients with unresectable hepatocellular carcinoma.

EAACI 2025: Daily Burden of Living With Eosinophilic Oesophagitis

Symptoms experienced over the past week were common and impactful, with over half of the participants reporting dysphagia and nearly half experiencing heartburn.

UK bond pushes global vaccine funding past $10bn

A £300m bond has been issued by the International Finance Facility for Immunisation to fund vaccine programmes in lower-income countries.

EAACI 2025: Oral Nut Immunotherapy Leads to Lasting Tolerance

These findings suggest that most children can maintain tolerance to nuts even after a short period without exposure, following a structured course of N-OIT.

Breakthrough Blood Test Detects Coeliac Disease Without Gluten

A novel blood-based assay could transform coeliac disease diagnosis, particularly for patients already on a gluten-free diet.

EULAR 2025: Single-Cell Study Reveals Pro-Inflammatory Fibroblast Signature in Very Early Systemic Sclerosis

A new study from EULAR 2025 shows that patients with very early systemic sclerosis have a distinct pro-inflammatory fibroblast profile before any signs of fibrosis appear.

EAACI 2025: Chronic Urticaria Linked to Higher Rates of Comorbid Diseases

Conducted across 19 countries, this large-scale observational study gathered data from 1,392 patients with CSU and 1,374 healthy controls.

Onradivir Rivals Oseltamivir in Treating Influenza A

A large Phase III trial has found that onradivir, a novel PB2 polymerase inhibitor, significantly shortens recovery time in adults with uncomplicated influenza A.